Lower Risk Across All Key Outcomes with GLP-1RA Compared with DPP-4 inhibitors, GLP-1RA use was associated with significantly lower risks of MACE (hazard ratio [HR]: 0.66), VTE (HR: 0.49), kidney disease progression (HR: 0.77), and all-cause mortality (HR: 0.26)
Ltd., HanAll Biopharma Co
Thyroid concerns : Medullary thyroid carcinoma has been observed in rodent studies
Murthy SN, Hilaire RC, Casey DB, Badejo AM, McGee J, McNamara DB, Kadowitz PJ, Fonseca VA: The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats
Marketed under various brand names like Ozempic and Wegovy , Semaglutide , originally developed as a treatment for type 2 diabetes, has garnered attention for its remarkable potential to aid weight loss
The goal is to avoid the modest additional concentration effect that dehydration can add on top of your actual alcohol intake, and to protect your general wellbeing